6fdb
From Proteopedia
(Difference between revisions)
| (One intermediate revision not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Positively supercharged variant of the computationally designed cage protein O3-33== | |
| + | <StructureSection load='6fdb' size='340' side='right' caption='[[6fdb]], [[Resolution|resolution]] 3.62Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[6fdb]] is a 8 chain structure with sequence from [http://en.wikipedia.org/wiki/"bacillus_cholerae-suis"_smith_1894 "bacillus cholerae-suis" smith 1894]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6FDB OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6FDB FirstGlance]. <br> | ||
| + | </td></tr><tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">A7S24_10320, A7S72_11360, BUJ19_10850, CBI64_04620, CEP91_14370, IN36_13565, IN77_10790, IN95_23850, NGUA18_00608 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=28901 "Bacillus cholerae-suis" Smith 1894])</td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6fdb FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6fdb OCA], [http://pdbe.org/6fdb PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6fdb RCSB], [http://www.ebi.ac.uk/pdbsum/6fdb PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6fdb ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Oligonucleotide therapeutics have transformative potential in modern medicine but are poor drug candidates in themselves unless fitted with compensatory carrier systems. We describe a simple approach to transform a designed porous protein cage into a nucleic acid delivery vehicle. By introducing arginine mutations to the lumenal surface, a positively supercharged capsule is created, which can encapsidate oligonucleotides in vitro with high binding affinity. We demonstrate that the siRNA-loaded cage is taken up by mammalian cells and releases its cargo to induce RNAi and knockdown gene expression. These general concepts could also be applied to alternative scaffold designs, expediting the development of artificial protein cages toward delivery applications. | ||
| - | + | Rational Engineering of a Designed Protein Cage for siRNA Delivery.,Edwardson TGW, Mori T, Hilvert D J Am Chem Soc. 2018 Aug 9. doi: 10.1021/jacs.8b06442. PMID:30091604<ref>PMID:30091604</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | [[Category: | + | </div> |
| + | <div class="pdbe-citations 6fdb" style="background-color:#fffaf0;"></div> | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Bacillus cholerae-suis smith 1894]] | ||
[[Category: Edwardson, T]] | [[Category: Edwardson, T]] | ||
| - | [[Category: Mori, T]] | ||
[[Category: Hilvert, D]] | [[Category: Hilvert, D]] | ||
| + | [[Category: Mori, T]] | ||
| + | [[Category: Computationally designed cage protein]] | ||
| + | [[Category: De novo protein]] | ||
| + | [[Category: O3-33]] | ||
Current revision
Positively supercharged variant of the computationally designed cage protein O3-33
| |||||||||||
